| 3,5-Dichlorosalicylic acid | IC50 | 6.0 [1] |
| 3,5-Dichlorosalicylic acid | Ki | 58.0 [1] |
| 5-Chloro-4-Hydroxybiphenyl-3-Carboxylic Acid | IC50 | 100.0 [1] |
| 5-Chloro-4-Hydroxybiphenyl-3-Carboxylic Acid | Ki | 1.5 [1] |
| 5-Bromo-4-hydroxy-[1,1'-biphenyl]-3-carboxylic acid | IC50 | 460.0 [1] |
| 5-Bromo-4-hydroxy-[1,1'-biphenyl]-3-carboxylic acid | Ki | 4.0 [1], 4.1 [2], 14.0 [3], 113.0 [4] |
| Indomethacin | IC50 | 100000.0 [1], 130000.0 [2] |
| Indomethacin | Ki | 100000.0 [1] |
| Flufenamic acid | IC50 | 980.0 [1], 2640.0 [2] |
| Meclofenamic acid | IC50 | 740.0 [1], 3160.0 [2] |
| 3-((4-(Trifluoromethyl)Phenyl)Amino)Benzoic Acid | IC50 | 22700.0 [1] |
| 3-[(4-Nitrophenyl)amino]benzoic Acid | IC50 | 6740.0 [1] |
| Medroxyprogesterone acetate | IC50 | 700.0 [1], 1800.0 [2] |
| Jasmonic acid | Ki | 106000.0 [1] |
| Mefenamic acid | IC50 | 3910.0 [1] |
| Mefenamic acid | Ki | 810.0 [1] |
| 3,5-Dibromosalicylic acid | IC50 | 2300.0 [1] |
| 3,5-Dibromosalicylic acid | Ki | 9.0 [1] |
| 1-(4-Chlorobenzoyl)-5-methoxy-1H-indole-3-acetic acid | IC50 | 100.0 [1], 100000.0 [2] |
| 1-[4-(3,4-Dihydro-1H-isoquinolin-2-ylsulfonyl)phenyl]pyrrolidin-2-one | IC50 | 30000.0 [1] |
| 3-(4-Acetylanilino)benzoic acid | IC50 | 15600.0 [1] |
| 3-[1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]propanoic acid | IC50 | 100.0 [1], 100000.0 [2] |
| 2-[5-Methoxy-2-methyl-1-(4-methylbenzoyl)indol-3-yl]acetic acid | IC50 | 100.0 [1], 100000.0 [2] |
| 9-(4-Chlorobenzoyl)-6-methoxy-1,2,3,4-tetrahydrocarbazole-3-carboxylic acid | IC50 | 76.25 [1], 76250.0 [2] |
| 3a-Phenyl-3,4-dihydro-2H-pyrrolo[1,2-a]benzimidazol-1-one | IC50 | 167200.0 [1] |
| 3a-Phenyl-3,4-dihydro-2H-pyrrolo[1,2-a]benzimidazol-1-one | Ki | 83600.0 [1] |
| 5-Fluoro-4-hydroxybiphenyl-3-carboxylic acid | IC50 | 300.0 [1] |
| 5-Fluoro-4-hydroxybiphenyl-3-carboxylic acid | Ki | 1.3 [1] |
| 3-[(4-Bromophenyl)Amino]Benzoic Acid | IC50 | 31300.0 [1] |
| 3-(4-Tert-butylanilino)benzoic acid | IC50 | 35600.0 [1] |
| 3-[(4-Chlorophenyl)Amino]Benzoic Acid | IC50 | 30200.0 [1] |
| 2-[1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-N-(trifluoromethylsulfonyl)acetamide | IC50 | 100.0 [1], 100000.0 [2] |
| 1h-Indole-3-acetic acid,5-methoxy-2-methyl-1-[4-(trifluoromethyl)benzoyl]- | IC50 | 100.0 [1], 100000.0 [2] |
| 3-[1-(4-Chlorobenzoyl)-5-methoxy-3-methylindol-2-yl]propanoic acid | IC50 | 17.73 [1], 17730.0 [2] |
| 3-[1-(4-Chlorobenzoyl)-5-methoxy-3-methylindol-2-yl]-N-methylsulfonylpropanamide | IC50 | 100.0 [1], 100000.0 [2] |
| 3-[1-(4-Chlorobenzoyl)-3-ethyl-5-methoxyindol-2-yl]propanoic acid | IC50 | 30.71 [1], 30710.0 [2] |
| 2-[1-(4-Chlorobenzoyl)-5-methoxyindol-3-yl]-N-(trifluoromethylsulfonyl)acetamide | IC50 | 100.0 [1], 100000.0 [2] |
| 1-[4-(Chloromethyl)benzoyl]-2-methyl-5-methoxy-1H-indole-3-acetic acid | IC50 | 100.0 [1], 100000.0 [2] |
| Diazepam | IC50 | 5600.0 [1] |
| Naproxen | IC50 | 100000.0 [1] |
| Flurbiprofen | IC50 | 100000.0 [1] |
| Caffeic acid phenethyl ester | IC50 | 13000.0 [1] |
| Benzbromarone | IC50 | 48.0 [1] |
| Dexibuprofen | IC50 | 100000.0 [1] |
| Cloxazolam | Ki | 10000.0 [1] |
| 2'-Hydroxyflavone | IC50 | 6200.0 [1] |
| 3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic acid | IC50 | 20300.0 [1] |
| 1-[4-(Piperidine-1-sulfonyl)-phenyl]-pyrrolidin-2-one | IC50 | 30000.0 [1] |
| N-[(2,6-Dioxo-4-phenylcyclohexylidene)methyl]glycine | Ki | 56000.0 [1] |
| N-(4-(Cyano(Phenyl)Methyl)Phenyl)Acetamide | Ki | 89000.0 [1] |
| 3-[(2-Naphthylsulfonyl)amino]propanoic acid | Ki | 103000.0 [1] |
| alpha-Phenylcinnamic acid | IC50 | 7900.0 [1] |
| Morpholin-4-yl-(4-phenyl-piperazin-1-yl)-methanone | IC50 | 30000.0 [1] |
| 3-[(2-Phenylethyl)sulfamoyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-(1,3-Dihydro-isoindole-2-sulfonyl)-benzoic acid | IC50 | 3890.0 [1] |
| 4-[Methyl(phenylsulfonyl)amino]benzoic acid | Ki | 124000.0 [1] |
| 4-((3,4-Dihydroisoquinolin-2(1H)-yl)sulfonyl)benzoic acid | IC50 | 30000.0 [1] |
| 4-(4-Chlorophenyl)piperazinyl piperidyl ketone | IC50 | 30000.0 [1] |
| 6-Amino-4-(4-hydroxy-3-methoxyphenyl)-3-propyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | IC50 | 2490.0 [1] |
| Tetrabromophenolphthalein | IC50 | 33.0 [1] |
| 1-Phenylcyclopentanecarboxylic acid | IC50 | 72900.0 [1] |
| 7-Benzoyl-4,5-dihydro-1,4-benzoxazepin-3(2H)-one | Ki | 66000.0 [1] |
| 3-(2-Carboxyethylamino)naphthalene-2-carboxylic acid | Ki | 19000.0 [1] |
| [4-(4-Fluoro-phenyl)-piperazin-1-yl]-morpholin-4-yl-methanone | IC50 | 30000.0 [1] |
| (E)-3-[3-(3-Methylbut-2-enyl)-4-(3-phenylpropanoyloxy)phenyl]prop-2-enoic acid | IC50 | 100000.0 [1] |
| 1-{4-[(2-Methylpiperidin-1-yl)sulfonyl]phenyl}pyrrolidin-2-one | IC50 | 30000.0 [1] |
| [4-(4-Chlorophenyl)piperazin-1-yl](morpholin-4-yl)methanone | IC50 | 30000.0 [1] |
| 3-(3,4-Dihydroisoquinolin-2(1h)-Ylsulfonyl)-N-Methylbenzamide | IC50 | 30000.0 [1] |
| 1-(4-Bromophenyl)sulfonylindole-3-carboxylic acid | IC50 | 830.0 [1] |
| 1-Naphthalen-2-ylsulfonylpyrrolidine-3-carboxylic acid | IC50 | 22200.0 [1] |
| 5-Bromo-3-phenylsalicylic acid | Ki | 140.0 [1] |
| 3-(3,4-Dihydro-2H-quinoline-1-sulfonyl)-benzoic acid | IC50 | 30000.0 [1] |
| 3-(Naphthalen-2-ylsulfamoyl)benzoic acid | IC50 | 30000.0 [1] |
| 3-(3,4-Dihydro-1H-isoquinolin-2-ylsulfonyl)-N,N-dimethylbenzamide | IC50 | 30000.0 [1] |
| Morpholin-4-yl[4-(4-nitrophenyl)piperazin-1-yl]methanone | IC50 | 30000.0 [1] |
| 3-[(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)sulfonyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-(2,3-Dihydro-indole-1-sulfonyl)-benzoic acid | IC50 | 6610.0 [1] |
| 3-(3,4-Dihydro-1H-isoquinolin-2-ylsulfonyl)benzamide | IC50 | 30000.0 [1] |
| (E)-2-(4-Fluorophenyl)-3-(4-methylsulfonylphenyl)prop-2-enoic acid | IC50 | 23300.0 [1] |
| (E)-3-(4-Methylsulfonylphenyl)-2-phenylprop-2-enoic acid | IC50 | 30800.0 [1] |
| 3-[2-(4-Methoxyphenyl)ethylsulfamoyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-[2-(4-Chlorophenyl)ethylsulfamoyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-[2-(2-Fluorophenyl)ethylsulfamoyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-[2-(3-Chlorophenyl)ethylsulfamoyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-[(4-Nitronaphthalen-1-Yl)amino]benzoic Acid | IC50 | 11100.0 [1] |
| (S)-1-(Naphthalene-2-sulfonyl)-piperidine-3-carboxylic acid | IC50 | 30000.0 [1] |
| (R)-1-(Naphthalene-2-sulfonyl)-piperidine-3-carboxylic acid | IC50 | 30000.0 [1] |
| 1-[3-(2-Chlorophenyl)phenyl]sulfonylpiperidine-3-carboxylic acid | IC50 | 30000.0 [1] |
| 1-[4-(3-Phenylphenyl)phenyl]sulfonylpiperidine-3-carboxylic acid | IC50 | 730.0 [1] |
| 3-[(7-Iodo-3,4-dihydro-1H-isoquinolin-2-yl)sulfonyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-[(3-Methyl-3,4-dihydro-1H-isoquinolin-2-yl)sulfonyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-[(5-Bromo-3,4-dihydro-1H-isoquinolin-2-yl)sulfonyl]benzoic acid | IC50 | 30000.0 [1] |
| 1-Anthracen-2-ylsulfonylpiperidine-3-carboxylic acid | IC50 | 30000.0 [1] |
| 3-[(7-Chloro-3,4-dihydro-1H-isoquinolin-2-yl)sulfonyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-[2-(4-Methylphenyl)ethylsulfamoyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-[(5-Hydroxy-3,4-dihydro-1H-isoquinolin-2-yl)sulfonyl]benzoic acid | IC50 | 25600.0 [1] |
| 3-[(6-Nitro-3,4-dihydro-1H-isoquinolin-2-yl)sulfonyl]benzoic acid | IC50 | 30000.0 [1] |
| 3-(3,4-Dihydro-1H-isoquinolin-2-ylsulfonyl)-N-(2-pyridin-4-ylethyl)benzamide | IC50 | 30000.0 [1] |
| 3-[(5-Nitro-3,4-dihydro-1H-isoquinolin-2-yl)sulfonyl]benzoic acid | IC50 | 24600.0 [1] |
| 3-[(5-Chloro-3,4-dihydro-1H-isoquinolin-2-yl)sulfonyl]benzoic acid | IC50 | 30000.0 [1] |